Free Trial

Tenax Therapeutics (TENX) Competitors

Tenax Therapeutics logo
$5.76 +0.01 (+0.17%)
As of 07/8/2025 04:00 PM Eastern

TENX vs. HURA, IOBT, WHWK, OCX, VIRI, CRBP, ADAG, ENTX, ORMP, and JMAC

Should you be buying Tenax Therapeutics stock or one of its competitors? The main competitors of Tenax Therapeutics include TuHURA Biosciences (HURA), IO Biotech (IOBT), Whitehawk Therapeutics (WHWK), OncoCyte (OCX), Virios Therapeutics (VIRI), Corbus Pharmaceuticals (CRBP), Adagene (ADAG), Entera Bio (ENTX), Oramed Pharmaceuticals (ORMP), and Maxpro Capital Acquisition (JMAC). These companies are all part of the "pharmaceutical products" industry.

Tenax Therapeutics vs. Its Competitors

TuHURA Biosciences (NASDAQ:HURA) and Tenax Therapeutics (NASDAQ:TENX) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, profitability, earnings, risk, institutional ownership and analyst recommendations.

TuHURA Biosciences currently has a consensus target price of $12.67, indicating a potential upside of 410.75%. Tenax Therapeutics has a consensus target price of $17.50, indicating a potential upside of 203.82%. Given TuHURA Biosciences' stronger consensus rating and higher possible upside, equities analysts clearly believe TuHURA Biosciences is more favorable than Tenax Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TuHURA Biosciences
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
2 Strong Buy rating(s)
3.40
Tenax Therapeutics
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.25

In the previous week, TuHURA Biosciences had 6 more articles in the media than Tenax Therapeutics. MarketBeat recorded 6 mentions for TuHURA Biosciences and 0 mentions for Tenax Therapeutics. Tenax Therapeutics' average media sentiment score of 0.00 beat TuHURA Biosciences' score of -0.39 indicating that Tenax Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
TuHURA Biosciences Neutral
Tenax Therapeutics Neutral

TuHURA Biosciences' return on equity of 291.69% beat Tenax Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
TuHURA BiosciencesN/A 291.69% 122.09%
Tenax Therapeutics N/A -31.51%-30.35%

0.6% of TuHURA Biosciences shares are owned by institutional investors. Comparatively, 1.7% of Tenax Therapeutics shares are owned by institutional investors. 0.2% of TuHURA Biosciences shares are owned by insiders. Comparatively, 3.7% of Tenax Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TuHURA BiosciencesN/AN/A-$21.68MN/AN/A
Tenax TherapeuticsN/AN/A-$17.60M-$2.48-2.32

TuHURA Biosciences has a beta of 0.17, indicating that its share price is 83% less volatile than the S&P 500. Comparatively, Tenax Therapeutics has a beta of 1.61, indicating that its share price is 61% more volatile than the S&P 500.

Summary

TuHURA Biosciences beats Tenax Therapeutics on 6 of the 11 factors compared between the two stocks.

Get Tenax Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TENX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TENX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TENX vs. The Competition

MetricTenax TherapeuticsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$23.85M$2.87B$5.47B$8.95B
Dividend YieldN/A2.46%5.25%4.04%
P/E Ratio-2.3220.8027.0020.11
Price / SalesN/A286.27429.45119.84
Price / CashN/A41.1936.8257.86
Price / Book0.217.487.985.56
Net Income-$17.60M-$55.04M$3.16B$248.40M
7 Day Performance0.35%2.44%2.38%4.67%
1 Month Performance-1.71%1.90%2.17%6.64%
1 Year Performance80.56%4.35%33.80%21.31%

Tenax Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TENX
Tenax Therapeutics
1.2571 of 5 stars
$5.76
+0.2%
$17.50
+203.8%
+81.7%$23.85MN/A-2.329
HURA
TuHURA Biosciences
1.2298 of 5 stars
$2.23
+0.5%
$12.67
+468.0%
N/A$96.97MN/A0.00N/AGap Up
IOBT
IO Biotech
2.6461 of 5 stars
$1.39
-3.5%
$9.33
+571.5%
+22.9%$94.87MN/A-0.9330News Coverage
Gap Up
WHWK
Whitehawk Therapeutics
N/A$1.87
-3.1%
N/AN/A$90.92M$25.98M0.0040
OCX
OncoCyte
2.0104 of 5 stars
$3.18
+16.3%
$6.06
+90.9%
+5.8%$90.80M$3.84M-0.90120Positive News
VIRI
Virios Therapeutics
N/A$4.71
-1.3%
$5.00
+6.2%
+1,782.4%$90.71MN/A-17.445
CRBP
Corbus Pharmaceuticals
3.8097 of 5 stars
$6.90
-6.8%
$50.88
+637.3%
-85.2%$90.55MN/A-1.6440
ADAG
Adagene
2.0025 of 5 stars
$1.95
+1.6%
$8.00
+310.3%
-33.0%$90.45M$100K0.00260News Coverage
Gap Up
ENTX
Entera Bio
2.0339 of 5 stars
$1.90
-4.0%
$10.00
+426.3%
+0.6%$89.99M$180K-7.3120News Coverage
Positive News
Gap Up
ORMP
Oramed Pharmaceuticals
0.2597 of 5 stars
$2.25
+4.7%
N/A-17.1%$87.83M$1.34M-5.1110
JMAC
Maxpro Capital Acquisition
N/A$6.51
+1.5%
N/A+3,268.2%$87.42MN/A0.002,021

Related Companies and Tools


This page (NASDAQ:TENX) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners